Next Article in Journal
Pinocembrin Protects from AGE-Induced Cytotoxicity and Inhibits Non-Enzymatic Glycation in Human Insulin
Next Article in Special Issue
2-Oxonanonoidal Antibiotic Actinolactomycin Inhibits Cancer Progression by Suppressing HIF-1α
Previous Article in Journal
Bioavailable Menthol (Transient Receptor Potential Melastatin-8 Agonist) Induces Energy Expending Phenotype in Differentiating Adipocytes
Previous Article in Special Issue
Regulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer
Open AccessReview

Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?

1
UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland
2
School of Medicine, University College Dublin, Belfield, Dublin 4, Ireland
3
Systems Biology Ireland, University College Dublin, Belfield, Dublin 4, Ireland
*
Author to whom correspondence should be addressed.
Cells 2019, 8(5), 384; https://doi.org/10.3390/cells8050384
Received: 1 April 2019 / Revised: 24 April 2019 / Accepted: 24 April 2019 / Published: 26 April 2019
(This article belongs to the Special Issue Gene Regulation by HIFs during Hypoxia)
All metazoans that utilize molecular oxygen (O2) for metabolic purposes have the capacity to adapt to hypoxia, the condition that arises when O2 demand exceeds supply. This is mediated through activation of the hypoxia-inducible factor (HIF) pathway. At physiological oxygen levels (normoxia), HIF-prolyl hydroxylases (PHDs) hydroxylate proline residues on HIF-α subunits leading to their destabilization by promoting ubiquitination by the von-Hippel Lindau (VHL) ubiquitin ligase and subsequent proteasomal degradation. HIF-α transactivation is also repressed in an O2-dependent way due to asparaginyl hydroxylation by the factor-inhibiting HIF (FIH). In hypoxia, the O2-dependent hydroxylation of HIF-α subunits by PHDs and FIH is reduced, resulting in HIF-α accumulation, dimerization with HIF-β and migration into the nucleus to induce an adaptive transcriptional response. Although HIFs are the canonical substrates for PHD- and FIH-mediated protein hydroxylation, increasing evidence indicates that these hydroxylases may also have alternative targets. In addition to PHD-conferred alterations in protein stability, there is now evidence that hydroxylation can affect protein activity and protein/protein interactions for alternative substrates. PHDs can be pharmacologically inhibited by a new class of drugs termed prolyl hydroxylase inhibitors which have recently been approved for the treatment of anemia associated with chronic kidney disease. The identification of alternative targets of HIF hydroxylases is important in order to fully elucidate the pharmacology of hydroxylase inhibitors (PHI). Despite significant technical advances, screening, detection and verification of alternative functional targets for PHDs and FIH remain challenging. In this review, we discuss recently proposed non-HIF targets for PHDs and FIH and provide an overview of the techniques used to identify these. View Full-Text
Keywords: hypoxia; prolyl hydroxylation; hypoxia-inducible factor; mass spectrometry; HIF-prolyl hydroxylases; factor inhibiting HIF; Cep192; IKK-β; p105; p53; FOXO3a; OTUB1; MAPK6; RIPK4 hypoxia; prolyl hydroxylation; hypoxia-inducible factor; mass spectrometry; HIF-prolyl hydroxylases; factor inhibiting HIF; Cep192; IKK-β; p105; p53; FOXO3a; OTUB1; MAPK6; RIPK4
Show Figures

Figure 1

MDPI and ACS Style

Strowitzki, M.J.; Cummins, E.P.; Taylor, C.T. Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous? Cells 2019, 8, 384.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop